Cargando…
Expert Consensus on the Use of the PRESERFLO™ MicroShunt Device in the Treatment of Glaucoma: A Modified Delphi Panel
INTRODUCTION: The implantation of the PRESERFLO™ MicroShunt (PMS) device has been shown to significantly lower increased intraocular pressure (IOP) in patients with primary open-angle glaucoma (POAG). However, guidelines on best practice for patient selection and pre-/peri-/postoperative care manage...
Autores principales: | Khawaja, Anthony P., Stalmans, Ingeborg, Aptel, Florent, Barton, Keith, Beckers, Henny, Klink, Thomas, Marchini, Giorgio, Martínez de la Casa, Jose, Simonsen, Jan H., Töteberg-Harms, Marc, Vass, Clemens, Abegão Pinto, Luís |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9437199/ https://www.ncbi.nlm.nih.gov/pubmed/35797005 http://dx.doi.org/10.1007/s40123-022-00529-4 |
Ejemplares similares
-
Correction to: Expert Consensus on the Use of the PRESERFLO™ MicroShunt Device in the Treatment of Glaucoma: A Modified Delphi Panel
por: Khawaja, Anthony P., et al.
Publicado: (2022) -
Preliminary results of Preserflo Microshunt versus Preserflo Microshunt and Ologen implantation
por: Vastardis, Iraklis, et al.
Publicado: (2021) -
Evaluation of the Ultrastructural and In Vitro Flow Properties of the PRESERFLO MicroShunt
por: Barberá, Marta Ibarz, et al.
Publicado: (2021) -
Conjunctival erosion following a PRESERFLO® MicroShunt procedure
por: Fahy, Eamonn T., et al.
Publicado: (2022) -
A New and Easier Approach to Preserflo MicroShunt Implantation
por: Fea, Antonio M, et al.
Publicado: (2022)